Approval · Notice of Compliance 1361 · 2003
IDAMYCIN: Notice of Compliance 1361
Issued October 6, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1361
- Date
- October 6, 2003
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antineoplastic
Products in this notice
Medicinal ingredients
- IDARUBICIN HCL 25 MG per CAP
- IDARUBICIN HCL 5 MG per VIAL
- IDARUBICIN HCL 10 MG per VIAL
- IDARUBICIN HCL 5 MG per CAP
- IDARUBICIN HCL 10 MG per CAP